CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 280 filers reported holding CONMED CORP in Q2 2022. The put-call ratio across all filers is 2.14 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,650,914 | -70.8% | 16,370 | -60.6% | 0.00% | -50.0% |
| Q2 2023 | $5,645,822 | -9.8% | 41,547 | -31.1% | 0.00% | -33.3% |
| Q1 2023 | $6,262,238 | +238.3% | 60,295 | +188.7% | 0.00% | +200.0% |
| Q4 2022 | $1,850,981 | +32.9% | 20,882 | +20.1% | 0.00% | 0.0% |
| Q3 2022 | $1,393,000 | -25.9% | 17,381 | -11.5% | 0.00% | 0.0% |
| Q2 2022 | $1,881,000 | -48.8% | 19,637 | -20.6% | 0.00% | -50.0% |
| Q1 2022 | $3,674,000 | +185.9% | 24,734 | +172.8% | 0.00% | – |
| Q4 2021 | $1,285,000 | -37.3% | 9,066 | -42.2% | 0.00% | – |
| Q3 2021 | $2,050,000 | +20.9% | 15,674 | +27.0% | 0.00% | – |
| Q2 2021 | $1,696,000 | +465.3% | 12,338 | +436.2% | 0.00% | – |
| Q1 2021 | $300,000 | -6.8% | 2,301 | -20.1% | 0.00% | – |
| Q4 2020 | $322,000 | -21.3% | 2,879 | -44.6% | 0.00% | – |
| Q3 2020 | $409,000 | +91.1% | 5,195 | +39.1% | 0.00% | – |
| Q1 2020 | $214,000 | – | 3,736 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SCOPIA CAPITAL MANAGEMENT LP | 310,392 | $34,764,000 | 4.40% |
| Iron Triangle Partners LP | 148,317 | $16,612,000 | 2.15% |
| Ranger Investment Management | 294,664 | $33,002,000 | 1.74% |
| Penn Capital Management Company, LLC | 86,810 | $9,723,000 | 1.23% |
| EARNEST PARTNERS LLC | 1,575,336 | $176,438,000 | 1.22% |
| Champlain Investment Partners, LLC | 1,692,014 | $189,506,000 | 1.09% |
| MOODY ALDRICH PARTNERS LLC | 59,005 | $6,609,000 | 1.07% |
| Hood River Capital Management LLC | 232,412 | $26,030,000 | 0.86% |
| OAK RIDGE INVESTMENTS LLC | 80,775 | $9,047,000 | 0.80% |
| Huber Capital Management LLC | 18,620 | $2,085,000 | 0.68% |